Dwi Wanna

Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Battle with Stage 3C Breast Cancer

• Survivorship and Post-Treatment

Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Battle with Stage 3C Breast Cancer

Dwi Wanna July 31, 2026

By Medical News Desk August 25, 2025 In the landscape of modern oncology, a medical diagnosis is...

Read More Read more about Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Battle with Stage 3C Breast Cancer

A Breakthrough in Cancer Interception: New KRAS-Targeting Vaccine Shows Promise Against Pancreatic Cancer

• Clinical Oncology Education

A Breakthrough in Cancer Interception: New KRAS-Targeting Vaccine Shows Promise Against Pancreatic Cancer

Dwi Wanna July 31, 2026

In a landmark advancement for oncology, researchers have unveiled results from a first-in-human phase I clinical trial...

Read More Read more about A Breakthrough in Cancer Interception: New KRAS-Targeting Vaccine Shows Promise Against Pancreatic Cancer

Market Turbulence: Alnylam Pharmaceuticals Faces Investor Skepticism Following Revenue Miss and Guidance Cut

• Chemotherapy and Targeted Therapy

Market Turbulence: Alnylam Pharmaceuticals Faces Investor Skepticism Following Revenue Miss and Guidance Cut

Dwi Wanna July 31, 2026

By BioPharma Dive Reporting Team Published July 30, 2026 Alnylam Pharmaceuticals, the pioneer of RNA interference (RNAi)...

Read More Read more about Market Turbulence: Alnylam Pharmaceuticals Faces Investor Skepticism Following Revenue Miss and Guidance Cut

Precision Oncology Takes Center Stage: The 2026 ASCO Annual Meeting Redefines Early Breast Cancer Care

• Patient Advocacy and Support

Precision Oncology Takes Center Stage: The 2026 ASCO Annual Meeting Redefines Early Breast Cancer Care

Dwi Wanna July 31, 2026

CHICAGO — The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting has solidified a paradigm shift...

Read More Read more about Precision Oncology Takes Center Stage: The 2026 ASCO Annual Meeting Redefines Early Breast Cancer Care

The Canvas of Resilience: How One Artist Transformed a Breast Cancer Diagnosis into a Masterpiece of Survival

• Survivorship and Post-Treatment

The Canvas of Resilience: How One Artist Transformed a Breast Cancer Diagnosis into a Masterpiece of Survival

Dwi Wanna July 31, 2026

By [Your Name/Journalistic Desk] March 26, 2026 Introduction: The Studio as a Sanctuary For Ariela Robinson, the...

Read More Read more about The Canvas of Resilience: How One Artist Transformed a Breast Cancer Diagnosis into a Masterpiece of Survival

The GLP-1 Dilemma: Examining the Impact of Weight-Loss Drugs on Post-Surgical Healing

• Breast Cancer Surgery and Reconstruction

The GLP-1 Dilemma: Examining the Impact of Weight-Loss Drugs on Post-Surgical Healing

Dwi Wanna July 30, 2026

As the global medical landscape shifts under the weight of the "GLP-1 revolution," plastic surgeons are finding...

Read More Read more about The GLP-1 Dilemma: Examining the Impact of Weight-Loss Drugs on Post-Surgical Healing

Ending the Diagnostic Odyssey: Can Early Exome Sequencing Revolutionize Outpatient Care?

• Genomics and Precision Medicine

Ending the Diagnostic Odyssey: Can Early Exome Sequencing Revolutionize Outpatient Care?

Dwi Wanna July 30, 2026

In the rapidly shifting landscape of clinical genomics, the journey for patients with undiagnosed rare diseases is...

Read More Read more about Ending the Diagnostic Odyssey: Can Early Exome Sequencing Revolutionize Outpatient Care?

The New Biotech Playbook: Emerging Startups Leverage Reverse Mergers to Access Public Capital

• Treatment Innovations

The New Biotech Playbook: Emerging Startups Leverage Reverse Mergers to Access Public Capital

Dwi Wanna July 29, 2026

By Gwendolyn Wu Published July 29, 2026 In a rapidly shifting landscape for life sciences, the traditional...

Read More Read more about The New Biotech Playbook: Emerging Startups Leverage Reverse Mergers to Access Public Capital

Blazing New Paths: The Strategic Evolution of American Biotech in a Globalized Market

• Chemotherapy and Targeted Therapy

Blazing New Paths: The Strategic Evolution of American Biotech in a Globalized Market

Dwi Wanna July 26, 2026

For the better part of a decade, the American biotechnology sector has faced a mounting crisis of...

Read More Read more about Blazing New Paths: The Strategic Evolution of American Biotech in a Globalized Market

Beyond Weight Loss: Boehringer Ingelheim’s Strategic Pivot Toward MASH with Survodutide

• Chemotherapy and Targeted Therapy

Beyond Weight Loss: Boehringer Ingelheim’s Strategic Pivot Toward MASH with Survodutide

Dwi Wanna July 26, 2026

For decades, the field of metabolic liver disease—specifically metabolic dysfunction-associated steatohepatitis (MASH)—was widely considered the "graveyard of...

Read More Read more about Beyond Weight Loss: Boehringer Ingelheim’s Strategic Pivot Toward MASH with Survodutide